Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 handwiki Vivi Li -- 5832 2022-10-17 01:41:50

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
HandWiki. Lactobacillus Vaccine. Encyclopedia. Available online: https://encyclopedia.pub/entry/29524 (accessed on 25 September 2026).
HandWiki. Lactobacillus Vaccine. Encyclopedia. Available at: https://encyclopedia.pub/entry/29524. Accessed September 25, 2026.
HandWiki. "Lactobacillus Vaccine" Encyclopedia, https://encyclopedia.pub/entry/29524 (accessed September 25, 2026).
HandWiki. (2022, October 17). Lactobacillus Vaccine. In Encyclopedia. https://encyclopedia.pub/entry/29524
HandWiki. "Lactobacillus Vaccine." Encyclopedia. Web. 17 October, 2022.
Lactobacillus Vaccine
Edit
The content is sourced from: https://handwiki.org/wiki/Medicine:Lactobacillus_vaccine

Lactobacillus vaccines are used in the therapy and prophylaxis of non-specific bacterial vaginitis and trichomoniasis. The vaccines consist of specific inactivated strains of Lactobacilli, called "aberrant" strains in the relevant literature dating from the 1980s. These strains were isolated from the vaginal secretions of patients with acute colpitis. The lactobacilli in question are polymorphic, often shortened or coccoid in shape and do not produce an acidic, anti-pathogenic vaginal environment. A colonization with aberrant lactobacilli has been associated with an increased susceptibility to vaginal infections and a high rate of relapse following antimicrobial treatment. Intramuscular administration of inactivated aberrant lactobacilli provokes a humoral immune response. The production of specific antibodies both in serum and in the vaginal secretion has been demonstrated. As a result of the immune stimulation, the abnormal lactobacilli are inhibited, the population of normal, rod-shaped lactobacilli can grow and exert its defense functions against pathogenic microorganisms.

lactobacilli lactobacillus vaginal infections

References

  1. Mendling, Werner (1995) (in German). Vaginose, Vaginitis und Zervizitis. Mit Bildteil zu Vulvovaginalerkrankungen. Springer-Verlag Berlin Heidelberg. doi:10.1007/978-3-662-10739-3. ISBN 978-3-540-58553-4.  https://dx.doi.org/10.1007%2F978-3-662-10739-3
  2. Petersen, Eiko E. (2005). "Impfung mit Gynatren – ergänzende Therapiemaßnahme bei Kolpitis" (in German). Gynäkologische Praxis 29 (2): 224. ISSN 0341-8677.  http://www.worldcat.org/issn/0341-8677
  3. Schmiedel, Stefan (February 2014). "Infektionen, Impfungen, Reisemedizin". in Gesenhues, Stefan; Zieschè, Rainer H.; Breetholt, Anne (in German). Praxisleitfaden Allgemeinmedizin (7th ed.). Urban & Fischer. pp. 449–571. doi:10.1016/C2012-0-02874-8. ISBN 978-3-437-22445-4.  https://dx.doi.org/10.1016%2FC2012-0-02874-8
  4. "Impfstoff Gynatren: Erfolgreiche Therapie rezidivierender Kolpitis" (in German). Deutsches Ärzteblatt International 98 (47): A-3146. 2001. 
  5. Újhelyi, Károly; Lázár, Erika (14–15 October 1983). "Role of Lactobacillus in Urogenital Inflammations and their Treatment with Vaccination". Symposium cum Participatione Internationali de Biocenosis Vaginae. Smolenice. 
  6. "Effect of immunopotentialization on rate of vaginal smear normalization according to appearance of cervical intraepithelial neoplasia". International Journal of Gynaecology and Obstetrics 28 (1): 41–4. January 1989. doi:10.1016/0020-7292(89)90542-0. PMID 2565829.  https://dx.doi.org/10.1016%2F0020-7292%2889%2990542-0
  7. "Kis súlyú újszülöttek arányszámának csökkentése terhesek lactobact vakcinációjával" (in Hungarian). Orvosi Hetilap [Physician's Weekly] 122 (37): 2263–8. September 1981. PMID 7312342.  http://www.ncbi.nlm.nih.gov/pubmed/7312342
  8. Lázár, Erika; Varga, Gyula; Institoris, István; Újhelyi, Károly (5–6 October 1982). "Meddőség kezelése a felszálló nőgyógyászati gyulladások gyógyításának új módszerével". in András Klinger (in Hungarian). A termékenység, családtervezés, születésszabályozás jelene és jövője: Tudományos kongresszus [Scientific Congress on the Present and Future of Fertility, Family Planning and Birth Control]. Budapest: Magyar Család- és Nővédelmi Tudományos Társaság [Pro Familia Hungarian Scientific Society]. pp. 75–77. 
  9. Lázár, Erika; Varga, Gyula; Institoris, István; Újhelyi, Károly (1988). "A koraszülést befolyásoló tényezők vizsgálata Kazincbarcikán, különös tekintettel a Lactobacillus vakcinációra" (in Hungarian). Magyar Nőorvosok Lapja [Journal of Hungarian Gynaecologists] (51): 353–356. 
  10. "Bacterial vaginitis: protection against infection and secretory immunoglobulin levels in the vagina after immunization therapy with Gynatren". Gynecologic and Obstetric Investigation 26 (3): 240–9. 1988. doi:10.1159/000293700. PMID 3240892.  https://dx.doi.org/10.1159%2F000293700
  11. "A new therapeutic approach in non-specific vaginitis". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 7–16. 1984. doi:10.1159/000269919. PMID 6537385.  https://dx.doi.org/10.1159%2F000269919
  12. "Effects of vaccination with SolcoTrichovac on the vaginal flora and the morphology of the Doederlein bacilli". Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2): 56–63. 1983. doi:10.1159/000269598. PMID 6629136.  https://dx.doi.org/10.1159%2F000269598
  13. "Effect of lactobacillus immunotherapy (Gynatren/SolcoTrichovac) on vaginal microflora when used for the prophylaxis and treatment of vaginitis". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 17–24. 1984. doi:10.1159/000269921. PMID 6537382.  https://dx.doi.org/10.1159%2F000269921
  14. "Gynatren/SolcoTrichovac in the treatment of non-specific vaginitides". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 50–7. 1984. doi:10.1159/000269926. PMID 6336151.  https://dx.doi.org/10.1159%2F000269926
  15. "Treatment of non-specific colpitis with Gynatren/SolcoTrichovac". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 58–62. 1984. doi:10.1159/000269927. PMID 6336152.  https://dx.doi.org/10.1159%2F000269927
  16. "Treatment of chronic colpo-vaginitis by stimulation of the immune system". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 81–90. 1984. doi:10.1159/000269930. PMID 6537387.  https://dx.doi.org/10.1159%2F000269930
  17. "Impfung gegen nichtspezifische bakterielle Vaginose. Doppelblinduntersuchung von Gynatren" (in German). Gynäkologisch-geburtshilfliche Rundschau 31 (3): 153–60. 1991. doi:10.1159/000271648. PMID 1761240.  https://dx.doi.org/10.1159%2F000271648
  18. "An audit of Gynatren (a Lactobacillus acidophilus lyophilisate) vaccination in women with recurrent bacterial vaginosis". International Journal of STD & AIDS 5 (4): 299. July 1994. doi:10.1177/095646249400500416. PMID 7948165.  https://dx.doi.org/10.1177%2F095646249400500416
  19. "Wirkung einer Laktobazillus-Vakzine auf die Trichomonas-Infektion der Frau. Vorläufige Ergebnisse" (in German). Fortschritte der Medizin 98 (41): 1624–7. November 1980. PMID 6781998.  http://www.ncbi.nlm.nih.gov/pubmed/6781998
  20. "SolcoTrichovac in the prophylaxis of trichomonad reinfection. A randomized double-blind study". Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2): 72–6. 1983. doi:10.1159/000269602. PMID 6354888.  https://dx.doi.org/10.1159%2F000269602
  21. "Double-blind comparative study of Trichomonas vaginalis infection: SolcoTrichovac versus placebo". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 44–9. 1984. doi:10.1159/000269925. PMID 6399488.  https://dx.doi.org/10.1159%2F000269925
  22. "Clinical experience using SolcoTrichovac in the treatment of trichomonas infections in women". Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2): 64–71. 1983. doi:10.1159/000269600. PMID 6629137.  https://dx.doi.org/10.1159%2F000269600
  23. "SolcoTrichovac in medical practice. An open, multicentre study to investigate the antitrichomonal vaccine SolcoTrichovac". Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2): 77–84. 1983. doi:10.1159/000269603. PMID 6629138.  https://dx.doi.org/10.1159%2F000269603
  24. "The therapeutic and prophylactic efficacy of SolcoTrichovac in women with trichomoniasis. Investigations in Cairo". Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2): 85–8. 1983. doi:10.1159/000269604. PMID 6629139.  https://dx.doi.org/10.1159%2F000269604
  25. "Immunotherapy in vaginal trichomoniasis--therapeutic and prophylactic effects of the vaccine SolcoTrichovac". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 63–9. 1984. doi:10.1159/000269928. PMID 6399489.  https://dx.doi.org/10.1159%2F000269928
  26. "Modification of the vaginal ecology by Gynatren/SolcoTrichovac". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 70–80. 1984. doi:10.1159/000269929. PMID 6537386.  https://dx.doi.org/10.1159%2F000269929
  27. Rajab, Khalil; D'Sa, Avita (1984). "Clinical Experience with SolcoTrichovac in the Treatment of Chronic Vaginal Trichomoniasis". Bahrain Medical Bulletin 6 (2): 51–52. 
  28. "Vacunación con SolcoTrichovac en trichomoniasis vaginal" (in Spanish). Revista Chilena de Obstetricia y Ginecologia 52 (3): 193–7. May 1987. PMID 3274669.  http://www.ncbi.nlm.nih.gov/pubmed/3274669
  29. "Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections". The Journal of Infectious Diseases 174 (5): 1058–63. November 1996. doi:10.1093/infdis/174.5.1058. PMID 8896509.  https://dx.doi.org/10.1093%2Finfdis%2F174.5.1058
  30. "Use of Lactobacillus to prevent infection by pathogenic bacteria". Microbes and Infection 4 (3): 319–24. March 2002. doi:10.1016/S1286-4579(02)01544-7. PMID 11909742.  https://dx.doi.org/10.1016%2FS1286-4579%2802%2901544-7
  31. Újhelyi, Károly; Philipp, György; Plank, György; Sági, Tamás (1973). "A trichomonas syndroma" (in Hungarian). Magyar Nőorvosok Lapja [Journal of Hungarian Gynaecologists] 36: 433–442. 
  32. "Intrauterine infection and preterm delivery". The New England Journal of Medicine 342 (20): 1500–7. May 2000. doi:10.1056/NEJM200005183422007. PMID 10816189.  https://dx.doi.org/10.1056%2FNEJM200005183422007
  33. "Preterm birth due to maternal infection: Causative pathogens and modes of prevention". European Journal of Clinical Microbiology & Infectious Diseases 25 (9): 562–9. September 2006. doi:10.1007/s10096-006-0190-3. PMID 16953371.  https://dx.doi.org/10.1007%2Fs10096-006-0190-3
  34. "Preterm premature rupture of the membranes". Obstetrics and Gynecology 101 (1): 178–93. January 2003. doi:10.1016/S0029-7844(02)02366-9. PMID 12517665.  https://dx.doi.org/10.1016%2FS0029-7844%2802%2902366-9
  35. "Second-trimester loss and subsequent pregnancy outcomes: What is the real risk?". American Journal of Obstetrics and Gynecology 197 (6): 581.e1–6. December 2007. doi:10.1016/j.ajog.2007.09.016. PMID 18060941.  https://dx.doi.org/10.1016%2Fj.ajog.2007.09.016
  36. Gynatren package insert. Hamburg, Germany: Strathmann GmbH & Co. KG; August 2017.
  37. "Heterovaccine against the trichomonas syndrome, and process for its preparation" US patent 4238478 http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=US4238478
  38. Gynevac package insert. Sajógalgóc, Hungary: Vakcina Kft.; July 2011.
  39. "Dauer der Schutzwirkung gegen Trichomoniasis nach Impfung mit SolcoTrichovac" (in German). Gynäkologisch-geburtshilfliche Rundschau 23 (3): 191–6. January 1983. doi:10.1159/000269512. PMID 6642286.  https://dx.doi.org/10.1159%2F000269512
  40. Király B., Györgyi (2017) (in Hungarian). A Gynevac tündöklése és bukása? Dr. Újhelyi Károly harmadik védőoltásának története. Budapest: V and B Kommunikációs Kft.. ISBN 978-963-12-9519-1. 
  41. "The ecologically wrong vaginal lactobacilli". Medical Hypotheses 36 (2): 126–130. October 1991. doi:10.1016/0306-9877(91)90253-U. PMID 1779915.  https://dx.doi.org/10.1016%2F0306-9877%2891%2990253-U
  42. "Bacterial non-specific vaginitis ('bacterial' vaginosis)". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 2–6. 1984. doi:10.1159/000269918. PMID 6537383.  https://dx.doi.org/10.1159%2F000269918
  43. "Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women". Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2): 27–38. 1983. doi:10.1159/000269590. PMID 6629132.  https://dx.doi.org/10.1159%2F000269590
  44. "New evidence elucidating the mechanism of action of Gynatren/SolcoTrichovac". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 29–37. 1984. doi:10.1159/000269923. PMID 6336149.  https://dx.doi.org/10.1159%2F000269923
  45. "Serological study with SolcoTrichovac, a vaccine against Trichomonas vaginalis infection in women". Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2): 39–45. 1983. doi:10.1159/000269592. PMID 6629134.  https://dx.doi.org/10.1159%2F000269592
  46. "IgA antibodies in the vaginal secretion after vaccination with SolcoTrichovac". Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2): 46–9. 1983. doi:10.1159/000269594. PMID 6629135.  https://dx.doi.org/10.1159%2F000269594
  47. "IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans". Proceedings of the National Academy of Sciences of the United States of America 84 (8): 2449–53. April 1987. doi:10.1073/pnas.84.8.2449. PMID 3470804. Bibcode: 1987PNAS...84.2449C.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=304669
  48. Kutteh, William H.; Mestecky, Jiri; Wira, Charles R. (7 January 2005). "Chapter 95 - Mucosal Immunity in the Human Female Reproductive Tract". in Mestecky, Jiri; Lamm, Michael E.; Ogra, Pearay et al.. Mucosal Immunology (3rd ed.). Academic Press. pp. 1631–1646. doi:10.1016/B978-012491543-5/50099-1. ISBN 978-0-12-491543-5.  https://dx.doi.org/10.1016%2FB978-012491543-5%2F50099-1
  49. "Induction of mucosal immune responses in the human genital tract". FEMS Immunology and Medical Microbiology 27 (4): 351–5. April 2000. doi:10.1111/j.1574-695X.2000.tb01449.x. PMID 10727891.  https://dx.doi.org/10.1111%2Fj.1574-695X.2000.tb01449.x
  50. "Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination". Infection and Immunity 62 (9): 3957–61. September 1994. doi:10.1128/IAI.62.9.3957-3961.1994. PMID 8063413.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=303053
  51. "A sensitive method for specific quantitation of secretory IgA". Scandinavian Journal of Immunology 6 (12): 1275–82. 1977. doi:10.1111/j.1365-3083.1977.tb00366.x. PMID 24264.  https://dx.doi.org/10.1111%2Fj.1365-3083.1977.tb00366.x
  52. Siegrist, Claire-Anne (2017). "Vaccine immunology". in Plotkin, Stanley; Orenstein, Walter; Offit, Paul et al.. Plotkin's Vaccines (7th ed.). Elsevier. pp. 16–34. ISBN 978-0-323-35761-6. 
  53. "Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses". The Journal of Clinical Investigation 99 (6): 1281–6. March 1997. doi:10.1172/JCI119286. PMID 9077537.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=507943
  54. "Vaccination strategies for mucosal immune responses". Clinical Microbiology Reviews 14 (2): 430–45. April 2001. doi:10.1128/CMR.14.2.430-445.2001. PMID 11292646.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=88982
  55. "Bacterial flora of the female genital tract: function and immune regulation". Best Practice & Research. Clinical Obstetrics & Gynaecology 21 (3): 347–54. June 2007. doi:10.1016/j.bpobgyn.2006.12.004. PMID 17215167.  https://dx.doi.org/10.1016%2Fj.bpobgyn.2006.12.004
  56. "Changes in the vaginal flora of trichomoniasis patients after vaccination with SolcoTrichovac". Gynäkologisch-geburtshilfliche Rundschau 23 (Suppl 2): 50–5. 1983. doi:10.1159/000269596. PMID 6354887.  https://dx.doi.org/10.1159%2F000269596
  57. "Therapie und Prophylaxe des unspezifischen Fluor vaginalis mit einer Laktobazillusvakzine" (in German). Gynäkologisch-geburtshilfliche Rundschau 23 (3): 205–207. 1983. doi:10.1159/000269691.  https://dx.doi.org/10.1159%2F000269691
  58. Philipp, György; Újhelyi, Károly; Plank, György (1974). "Trichomonas syndroma" (in Hungarian). Magyar Nőorvosok Lapja [Journal of Hungarian Gynaecologists] 37: 339–344. 
  59. Rüttgers, Helge, ed (1983). Trichomoniasis. Scientific papers of the Symposium on Trichomoniasis. Basle, October 20, 1981. 23. Basle: Karger. 1–91. doi:10.1159/isbn.978-3-318-01549-2. ISBN 978-3-8055-3751-3.  https://dx.doi.org/10.1159%2Fisbn.978-3-318-01549-2
  60. Rüttgers, Helge, ed (1984). Immunotherapy of Vaginal Infections. Scientific Papers Presented at the International Symposia in La Sarraz and Zurich, September 15 and 16, 1983. 24. Basle: Karger. 1–92. doi:10.1159/isbn.978-3-318-01684-0. ISBN 978-3-8055-4072-8.  https://dx.doi.org/10.1159%2Fisbn.978-3-318-01684-0
  61. Embley, T. Martin; Faquir, Nazir; Bossart, Walter; Collins, Matthew D. (1989). "Lactobacillus vaginalis sp. nov. from the Human Vagina". International Journal of Systematic and Evolutionary Microbiology 39 (3): 368–370. doi:10.1099/00207713-39-3-368.  https://dx.doi.org/10.1099%2F00207713-39-3-368
  62. "Hanseatisches Familienunternehmen mit Tradition" (in German). Strathmann GmbH & Co. KG. https://www.strathmann.de/index.php/en/historie. 
  63. "Strovac und Gynatren — Impfungen mit amtlichem ATC-Code" (in German). MMW - Fortschritte der Medizin 155 (18): 73. October 2013. 
  64. "GynVaccine - bei wiederkehrenden Beschwerden im Vaginalbereich" (in German). SymbioVaccin GmbH. https://www.symbiovaccin.de/patienteninfo/scheideninfektionen/. 
  65. Hecht, Angelika (2017). "Natürliche Hilfe bei Vaginose und Vulvovaginalkandidose − Mit Laktobazillen und GynVaccine die Döderleinflora stärken" (in German). Gyne 38 (3): 34–37. ISSN 0179-9185.  http://www.worldcat.org/issn/0179-9185
  66. "Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis". Journal of Clinical Microbiology 27 (2): 251–256. February 1989. doi:10.1128/jcm.27.2.251-256.1989. ISSN 0095-1137. PMID 2915019.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=267286
  67. "The Lactobacillus anomaly: total iron abstinence". Perspectives in Biology and Medicine 40 (4): 578–583. January 1997. doi:10.1353/pbm.1997.0072. ISSN 0031-5982. PMID 9269745.  https://dx.doi.org/10.1353%2Fpbm.1997.0072
  68. "On the iron requirement of lactobacilli grown in chemically defined medium". Current Microbiology 37 (1): 64–66. July 1998. doi:10.1007/s002849900339. ISSN 0343-8651. PMID 9625793.  https://dx.doi.org/10.1007%2Fs002849900339
  69. "Lactobacillus iners, the unusual suspect". Research in Microbiology 168 (9–10): 826–836. September 2017. doi:10.1016/j.resmic.2017.09.003. PMID 28951208.  https://dx.doi.org/10.1016%2Fj.resmic.2017.09.003
  70. "Molecular identification of bacteria associated with bacterial vaginosis". The New England Journal of Medicine 353 (18): 1899–1911. November 2005. doi:10.1056/nejmoa043802. ISSN 0028-4793. PMID 16267321.  https://dx.doi.org/10.1056%2Fnejmoa043802
  71. "The vaginal microbiome: new information about genital tract flora using molecular based techniques". BJOG: An International Journal of Obstetrics and Gynaecology 118 (5): 533–549. January 2011. doi:10.1111/j.1471-0528.2010.02840.x. ISSN 0306-5456. PMID 21251190.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3055920
  72. "Vaginal microbiota". Microbiota of the human body. Advances in Experimental Medicine and Biology. 902 (1st ed.). Springer International Publishing. 2016. pp. 83–93. doi:10.1007/978-3-319-31248-4_6. ISBN 978-3-319-31246-0.  https://dx.doi.org/10.1007%2F978-3-319-31248-4_6
  73. "Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery". Scientific Reports 4: 5136. May 2014. doi:10.1038/srep05136. ISSN 2045-2322. PMID 24875844. Bibcode: 2014NatSR...4E5136P.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4038809
  74. "The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk". Microbiome 5 (1): 6. January 2017. doi:10.1186/s40168-016-0223-9. ISSN 2049-2618. PMID 28103952.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5244550
  75. "Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners". BMC Microbiology 7: 115. December 2007. doi:10.1186/1471-2180-7-115. ISSN 1471-2180. PMID 18093311.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2233628
  76. "Long, uniform Lactobacilli (Döderlein's Bacteria): a new risk factor for postoperative infection after first-trimester abortion". Infectious Diseases in Obstetrics and Gynecology 3 (3): 102–109. January 1995. doi:10.1155/s106474499500041x. ISSN 1064-7449. PMID 18476030.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2364428
  77. "Cytolytic vaginosis". American Journal of Obstetrics and Gynecology 165 (4 Pt 2): 1245–1249. October 1991. doi:10.1016/s0002-9378(12)90736-x. ISSN 0002-9378. PMID 1951582.  https://dx.doi.org/10.1016%2Fs0002-9378%2812%2990736-x
  78. "Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections". mBio 4 (4). August 2013. doi:10.1128/mbio.00460-13. ISSN 2161-2129. PMID 23919998.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3735189
  79. "Probiotic agents to protect the urogenital tract against infection". The American Journal of Clinical Nutrition 73 (2 Suppl): 437S–443S. February 2001. doi:10.1093/ajcn/73.2.437s. ISSN 0002-9165. PMID 11157354.  https://dx.doi.org/10.1093%2Fajcn%2F73.2.437s
  80. "Lactobacilli at the front line of defense against vaginally acquired infections". Future Microbiology 6 (5): 567–582. 2011. doi:10.2217/fmb.11.36. ISSN 1746-0921. PMID 21585263.  https://dx.doi.org/10.2217%2Ffmb.11.36
  81. "S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions". Proceedings of the National Academy of Sciences of the United States of America 105 (49): 19474–19479. December 2008. doi:10.1073/pnas.0810305105. ISSN 0027-8424. PMID 19047644. Bibcode: 2008PNAS..10519474K.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2592362
  82. "Vaginal lactobacilli induce differentiation of monocytic precursors toward Langerhans-like cells: in vitro evidence". Frontiers in Immunology 9: 2437. October 2018. doi:10.3389/fimmu.2018.02437. ISSN 1664-3224. PMID 30410487.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=6211368
  83. "Inerolysin, a cholesterol-dependent cytolysin produced by Lactobacillus iners". Journal of Bacteriology 193 (5): 1034–1041. December 2010. doi:10.1128/jb.00694-10. ISSN 2045-2322. PMID 21169489.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3067590
  84. "Inerolysin and vaginolysin, the cytolysins implicated in vaginal dysbiosis, differently impair molecular integrity of phospholipid membranes". Scientific Reports 9 (1): 10606. July 2019. doi:10.1038/s41598-019-47043-5. ISSN 2045-2322. PMID 31337831. Bibcode: 2019NatSR...910606R.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=6650466
  85. "Vaginal lactobacillosis". American Journal of Obstetrics and Gynecology 170 (3): 857–861. March 1994. doi:10.1016/s0002-9378(94)70298-5. ISSN 0002-9378. PMID 8141216.  https://dx.doi.org/10.1016%2Fs0002-9378%2894%2970298-5
  86. "Normal and abnormal vaginal microbiota". Journal of Laboratory Medicine 40 (4): 239–246. January 2016. doi:10.1515/labmed-2016-0011. ISSN 0342-3026.  https://dx.doi.org/10.1515%2Flabmed-2016-0011
  87. "Candidiasis, bacterial vaginosis, trichomoniasis and other vaginal conditions affecting the vulva". Vulvar disease (1st ed.). Springer, Cham. 2019. pp. 167–205. doi:10.1007/978-3-319-61621-6_24. ISBN 978-3-319-61620-9.  https://dx.doi.org/10.1007%2F978-3-319-61621-6_24
  88. "The adherence of Trichomonas vaginalis to host ectocervical cells is influenced by lactobacilli". Sexually Transmitted Infections 89 (6): 455–459. May 2013. doi:10.1136/sextrans-2013-051039. ISSN 1368-4973. PMID 23720602.  https://dx.doi.org/10.1136%2Fsextrans-2013-051039
  89. "Mouse intravaginal infection with Trichomonas vaginalis and role of Lactobacillus acidophilus in sustaining infection". Infection and Immunity 60 (6): 2375–2379. June 1992. doi:10.1128/iai.60.6.2375-2379.1992. ISSN 0019-9567. PMID 1587604.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=257168
  90. "Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis". Obstetrics and Gynecology 99 (3): 419–425. March 2002. doi:10.1016/s0029-7844(01)01759-8. PMID 11864668.  https://dx.doi.org/10.1016%2Fs0029-7844%2801%2901759-8
  91. "Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment". Journal of Clinical Microbiology 45 (3): 1016–1018. January 2007. doi:10.1128/jcm.02085-06. ISSN 0095-1137. PMID 17202272.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1829144
  92. "Vaginal lactobacillosis". Journal of Clinical Gynecology and Obstetrics 3 (3): 81–84. 2014. doi:10.14740/jcgo278e.  https://dx.doi.org/10.14740%2Fjcgo278e
  93. "Wpływ T. vaginalis na fizjologiczna florę pochwy" (in Polish). Wiadomości Parazytologiczne 23 (5): 519–523. January 1977. ISSN 0043-5163. PMID 415437.  http://www.worldcat.org/issn/0043-5163
  94. "Microflora associated with Trichomonas vaginalis and vaccination against vaginal trichomoniasis". Trichomonads parasitic in humans (1st ed.). Springer, New York, NY. 1990. pp. 213–224. doi:10.1007/978-1-4612-3224-7_10. ISBN 978-1-4612-7922-8.  https://dx.doi.org/10.1007%2F978-1-4612-3224-7_10
  95. "An explanation of the mode of action of Gynatren/SolcoTrichovac based on immunological considerations". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 25–8. 1984. doi:10.1159/000269922. PMID 6537384.  https://dx.doi.org/10.1159%2F000269922
  96. "The destructive effect of SolcoTrichovac-induced serum antibodies on Trichomonas vaginalis; an electron microscopic investigation". Gynäkologisch-geburtshilfliche Rundschau 24 (Suppl 3): 38–43. 1984. doi:10.1159/000269924. PMID 6336150.  https://dx.doi.org/10.1159%2F000269924
  97. "Does lactobacillus vaccine for trichomoniasis, Solco Trichovac, induce antibody reactive with Trichomonas vaginalis?". Genitourinary Medicine 64 (2): 118–23. April 1988. doi:10.1136/sti.64.2.118. PMID 3290091.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1194170
  98. "Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis". Genitourinary Medicine 62 (2): 107–10. April 1986. doi:10.1136/sti.62.2.107. PMID 3522408.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1011910
  99. "A recently transferred cluster of bacterial genes in Trichomonas vaginalis--lateral gene transfer and the fate of acquired genes". BMC Evolutionary Biology 14: 119. June 2014. doi:10.1186/1471-2148-14-119. ISSN 1471-2148. PMID 24898731.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4082486
  100. "The protozoan Trichomonas vaginalis targets bacteria with laterally-acquired NlpC/P60 peptidoglycan hydrolases". mBio 9 (6). December 2018. doi:10.1128/mbio.01784-18. PMID 30538181.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=6299479
  101. "Lateral gene transfer and metabolic adaptation in the human parasite Trichomonas vaginalis". Molecular Biology and Evolution 17 (11): 1769–73. November 2000. doi:10.1093/oxfordjournals.molbev.a026275. ISSN 0737-4038. PMID 11070064.  https://dx.doi.org/10.1093%2Foxfordjournals.molbev.a026275
  102. "Acute enteric infections alter commensal microbiota: new mechanisms in post-infectious intestinal inflammatory disorders". Old Herborn University Seminar Monograph: Persisting Consequences of Intestinal Infection 27: 87–100. 2014. 
  103. "Functional flexibility of intestinal IgA - broadening the fine line". Frontiers in Immunology 3: 100. May 2012. doi:10.3389/fimmu.2012.00100. ISSN 1664-3224. PMID 22563329.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3342566
  104. "Life in the littoral zone: lactobacilli losing the plot". Sexually Transmitted Infections 81 (2): 100–102. April 2005. doi:10.1136/sti.2003.007161. ISSN 1368-4973. PMID 15800083.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1764678
  105. "Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili". Molecular Immunology 43 (4): 378–387. February 2006. doi:10.1016/j.molimm.2005.02.013. ISSN 0161-5890. PMID 16310051.  https://dx.doi.org/10.1016%2Fj.molimm.2005.02.013
  106. "Gut microbiota utilize immunoglobulin A for mucosal colonization". Science 360 (6390): 795–800. May 2018. doi:10.1126/science.aaq0926. ISSN 0036-8075. PMID 29724905.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5973787
  107. "Roundtrip ticket for secretory IgA: role in mucosal homeostasis?". Journal of Immunology 178 (1): 27–32. January 2007. doi:10.4049/jimmunol.178.1.27. ISSN 0022-1767. PMID 17182536.  https://dx.doi.org/10.4049%2Fjimmunol.178.1.27
  108. "Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation". Journal of Immunology 168 (1): 102–107. January 2002. doi:10.4049/jimmunol.168.1.102. ISSN 0022-1767. PMID 11751952.  https://dx.doi.org/10.4049%2Fjimmunol.168.1.102
  109. "Molecular mechanisms of induction of tolerant and tolerogenic intestinal dendritic cells in mice". Journal of Immunology Research 2016: 1958650. February 2016. doi:10.1155/2016/1958650. ISSN 2314-8861. PMID 26981546.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4766351
  110. "Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria". Immunology 115 (2): 153–162. June 2005. doi:10.1111/j.1365-2567.2005.02159.x. ISSN 0019-2805. PMID 15885120.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1782138
  111. "IgA response to symbiotic bacteria as a mediator of gut homeostasis". Cell Host & Microbe 2 (5): 328–339. November 2007. doi:10.1016/j.chom.2007.09.013. ISSN 1931-3128. PMID 18005754.  https://dx.doi.org/10.1016%2Fj.chom.2007.09.013
  112. "Role of commensal gut bacteria in inflammatory bowel diseases". Gut Microbes 3 (6): 544–555. October 2012. doi:10.4161/gmic.22156. ISSN 1949-0984. PMID 23060017.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3495792
  113. "Identification of common vaginal Lactobacilli immunoreactive proteins by immunoproteomic techniques". World Journal of Microbiology & Biotechnology 35 (10): 161. October 2019. doi:10.1007/s11274-019-2736-4. ISSN 0959-3993. PMID 31608422.  https://dx.doi.org/10.1007%2Fs11274-019-2736-4
  114. "Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis". Sexually Transmitted Diseases 31 (7): 393–400. July 2004. doi:10.1097/01.OLQ.0000130454.83883.E9. ISSN 0148-5717. PMID 15215693.  https://dx.doi.org/10.1097%2F01.OLQ.0000130454.83883.E9
  115. "Impairment of the mucosal immune system: IgA and IgM cleavage detected in vaginal washings of a subgroup of patients with bacterial vaginosis". The Journal of Infectious Diseases 178 (6): 1698–1706. December 1998. doi:10.1086/314505. ISSN 0022-1899. PMID 9815222.  https://dx.doi.org/10.1086%2F314505
  116. "Hydrolysis of secreted sialoglycoprotein immunoglobulin A (IgA) in ex vivo and biochemical models of bacterial vaginosis". The Journal of Biological Chemistry 287 (3): 2079–2089. December 2011. doi:10.1074/jbc.m111.278135. ISSN 0021-9258. PMID 22134918.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3265887
More
©Text is available under the terms and conditions of the Creative Commons-Attribution ShareAlike (CC BY-SA) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Others
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
HandWiki
View Times: 2.4K
Entry Collection: HandWiki
Revision: 1 time (View History)
Update Date: 17 Oct 2022
Table of Contents
    Notice
    You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
    OK
    Confirm
    Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
    Yes
    No
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    There is no comment~
    ${ textCharacter }/${ maxCharacter }
    Submit
    Cancel
    ${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
    Submit
    Cancel
    Confirm
    Are you sure to Delete?
    Yes No
    Academic Video Service
    Feedback